These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 25732947)

  • 1. [Monoclonal antibodies for the treatment of multiple sclerosis].
    Sánchez-Seco VG; Casanova Peño I; Arroyo González R
    Med Clin (Barc); 2014 Dec; 143 Suppl 3():30-4. PubMed ID: 25732947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological treatment of multiple sclerosis].
    Sørensen PS; Sellebjerg F
    Ugeskr Laeger; 2008 Jun; 170(24):2156-9. PubMed ID: 18565303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies in the treatment of multiple sclerosis.
    Di Pauli F; Berger T; Reindl M
    Curr Med Chem; 2009; 16(36):4858-68. PubMed ID: 19929782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral Treatment of Multiple Sclerosis: The Advent of Monoclonal Antibodies.
    Singer BA
    Semin Neurol; 2016 Apr; 36(2):140-7. PubMed ID: 27116720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Agents for Relapsing Forms of Multiple Sclerosis.
    Straus Farber R; Harel A; Lublin F
    Annu Rev Med; 2016; 67():309-21. PubMed ID: 26394285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New biological agents in the treatment of multiple sclerosis.
    Buc M
    Bratisl Lek Listy; 2018; 119(4):191-197. PubMed ID: 29663814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific immune intervention with monoclonal antibodies for the treatment of multiple sclerosis.
    Trebst C; Voss E; Skripuletz T; Stangel M
    Curr Med Chem; 2010; 17(7):640-50. PubMed ID: 20088763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating multiple sclerosis with monoclonal antibodies: a 2013 update.
    Deiß A; Brecht I; Haarmann A; Buttmann M
    Expert Rev Neurother; 2013 Mar; 13(3):313-35. PubMed ID: 23448220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies in treatment of multiple sclerosis.
    Rommer PS; Dudesek A; Stüve O; Zettl UK
    Clin Exp Immunol; 2014 Mar; 175(3):373-84. PubMed ID: 24001305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging monoclonal antibody therapies for multiple sclerosis.
    Cree B
    Neurologist; 2006 Jul; 12(4):171-8. PubMed ID: 16832236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Emerging therapies for multiple sclerosis].
    de Lorenzo-Pinto A; Rodríguez-González CG; Ais-Larisgoitia A
    Med Clin (Barc); 2013 Jan; 140(2):76-82. PubMed ID: 22766059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody treatments for multiple sclerosis.
    Rose JW; Foley J; Carlson N
    Curr Neurol Neurosci Rep; 2008 Sep; 8(5):419-26. PubMed ID: 18713579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal antibodies in [corrected] development in [corrected] multiple sclerosis].
    Sastre-Garriga J; Montalban X
    Neurologia; 2011 Nov; 26(9):556-62. PubMed ID: 21481981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal Antibodies for Multiple Sclerosis: An Update.
    Graf J; Aktas O; Rejdak K; Hartung HP
    BioDrugs; 2019 Feb; 33(1):61-78. PubMed ID: 30604390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis.
    Gensicke H; Leppert D; Yaldizli Ö; Lindberg RL; Mehling M; Kappos L; Kuhle J
    CNS Drugs; 2012 Jan; 26(1):11-37. PubMed ID: 22171583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis - established and novel therapeutic approaches.
    Ehling R; Berger T; Reindl M
    Cent Nerv Syst Agents Med Chem; 2010 Mar; 10(1):3-15. PubMed ID: 20236038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
    Wingerchuk DM; Carter JL
    Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newer agents in the treatment of multiple sclerosis.
    Pawate S; Bagnato F
    Neurologist; 2015 Apr; 19(4):104-17. PubMed ID: 25888198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of new therapies for multiple sclerosis].
    Holmøy T; Celius EG
    Tidsskr Nor Laegeforen; 2011 May; 131(8):832-6. PubMed ID: 21556088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta.
    Bielekova B; Richert N; Howard T; Blevins G; Markovic-Plese S; McCartin J; Frank JA; Würfel J; Ohayon J; Waldmann TA; McFarland HF; Martin R
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8705-8. PubMed ID: 15161974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.